دواعي استعمال يوروميتكسان 400مجم/4مل 15 امبول

Mesna 400mg/4ml solution for intravenous injection, a uroprotective thiol used to prevent ifosfamide-induced haemorrhagic cystitis.

• Prophylaxis to reduce the incidence of ifosfamide-induced haemorrhagic cystitis (not for haematuria from other causes such as thrombocytopenia).الفئة: Patients receiving ifosfamideDailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to mesna or any excipient (including benzyl alcohol in the US multidose vial).نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Systemic hypersensitivity reactions including anaphylaxis; DRESS, Stevens-Johnson syndrome/TEN and other skin/mucosal reactions - discontinue and give supportive care.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• False-positive urine ketone (nitroprusside) and ascorbic acid tests, and falsely low enzymatic CPK results, may occur.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Benzyl alcohol-preserved solutions: avoid in premature neonates and low-birth-weight infants (gasping syndrome).نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Used with ifosfamide, which can cause fetal harm; animal studies of mesna alone showed no adverse developmental outcomes. Verify pregnancy status and use effective contraception (females 6 months, males 3 months after last dose).نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Do not breastfeed during treatment and for 1 week after the last dose of mesna or ifosfamide.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Monitor for haematuria and for hypersensitivity/skin reactions.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)